Sartorius Stedim Biotech revenue and financials
In the fiscal year ended December 2025, Sartorius Stedim Biotech reported revenue of €2.97B (+6.74% year over year). Net income was €265.6M, a net margin of 9.0%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +6.74%
- 2025 vs 2024
- Net income growth
- +51.68%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 6.3%
How Sartorius Stedim Biotech is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 9.2% a year on average over the last 5 years
Compound annual growth rate: from €1.91B in 2020 to €2.97B in 2025.
Operating margin fell from 30.2% to 18.1%
Operating income over revenue, 2022 → 2025: 12.1 percentage points.
Profits turn into cash: free cash flow equal to 139% of net income
Totals for fiscal years 2023–2025: free cash flow €1.05B, net income €751M.
Shares outstanding up 5.6% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,968 | 2,780 | 2,776 | 3,493 | 2,887 | 1,910 | 1,441 | 1,212 | 1,081 | 1,052 |
| Cost of revenue | 1,622 | 1,573 | 1,542 | 1,675 | 1,334 | 907 | 692 | 583 | 526 | 525 |
| Gross profit | 1,345 | 1,207 | 1,234 | 1,817 | 1,553 | 1,003 | 748 | 630 | 555 | 527 |
| Selling, general and administrative | 663 | 650 | 618 | 612 | 532 | 392 | 318 | 283 | 258 | 244 |
| Research and development | 133 | 144 | 130 | 132 | 111 | 84.5 | 79.2 | 60.6 | 53.2 | 47.5 |
| Operating income | 538 | 396 | 469 | 1,054 | 920 | 503 | 348 | 287 | 251 | 241 |
| EBIT | 538 | 396 | 469 | 1,054 | 920 | 503 | 348 | 287 | 251 | 241 |
| EBITDA | 778 | 629 | 658 | 1,197 | 1,031 | 577 | 402 | 342 | 296 | 281 |
| Interest expense | 138 | 148 | 115 | 18.2 | 10.2 | 6.5 | 3.9 | 3.3 | 3.8 | 3.8 |
| Pre-tax income | 373 | 219 | 402 | 1,130 | 647 | 461 | 317 | 285 | 221 | 213 |
| Income tax | 107 | 40.7 | 89.2 | 251 | 232 | 122 | 81.4 | 74.6 | 56.8 | 57.1 |
| Net income | 266 | 175 | 310 | 876 | 414 | 336 | 235 | 208 | 161 | 154 |
| Net income to common shareholders | 266 | 175 | 310 | 876 | 414 | 336 | 235 | 208 | 161 | 154 |
| Basic EPS | 2.73 | 1.81 | 3.37 | 9.51 | 4.50 | 3.64 | 2.54 | 2.26 | 1.75 | 1.67 |
| Diluted EPS | 2.73 | 1.81 | 3.37 | 9.51 | 4.50 | 3.64 | 2.54 | 2.26 | 1.75 | 1.67 |
| Average shares (basic) | 97.3 | 96.8 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 |
| Average shares (diluted) | 97.3 | 96.8 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 | 92.2 |
| Dividend per share | 0.69 | 0.69 | 0.69 | 1.44 | 1.26 | 0.68 | 0.34 | 0.57 | 0.46 | 0.42 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 762 | 766 | 762 | 772 | 706 | 745 | 745 | 751 | 655 | 706 | 667 | 707 |
| Cost of revenue | 419 | 407 | 416 | 455 | 378 | 400 | 388 | 435 | 380 | 400 | 359 | 453 |
| Gross profit | 343 | 359 | 345 | 317 | 327 | 345 | 356 | 316 | 275 | 306 | 308 | 254 |
| Selling, general and administrative | 159 | 163 | 163 | 172 | 158 | 167 | 167 | 176 | 156 | 158 | 161 | 172 |
| Research and development | 33.7 | 35.3 | 38.4 | 31.7 | 30.1 | 32.1 | 39.2 | 37.1 | 37.3 | 35.2 | 34.5 | 37.0 |
| Operating income | 151 | 154 | 149 | 133 | 135 | 129 | 141 | 110 | 70.7 | 104 | 110 | 126 |
| EBIT | 151 | 154 | 149 | 133 | 135 | 129 | 141 | 110 | 70.7 | 104 | 110 | 126 |
| EBITDA | 233 | 233 | 230 | 139 | 214 | 207 | 219 | 123 | 147 | 179 | 180 | 139 |
| Interest expense | 29.3 | 34.2 | 46.5 | 24.5 | 51.4 | 30.9 | 63.3 | 21.7 | 37.9 | 51.7 | 48.7 | 109 |
| Pre-tax income | 130 | 127 | 119 | 77.7 | 87.4 | 92.5 | 115 | 40.9 | 35.5 | 65.4 | 77.0 | 58.8 |
| Income tax | 33.9 | 32.9 | 31.0 | 30.5 | 22.7 | 24.0 | 30.0 | -5.4 | 9.2 | 16.8 | 20.0 | 17.0 |
| Net income | 95.5 | 93.0 | 88.1 | 47.3 | 64.2 | 68.5 | 85.6 | 45.6 | 25.5 | 47.6 | 56.1 | 40.4 |
| Net income to common shareholders | 95.5 | 93.0 | 88.1 | 47.3 | 64.2 | 68.5 | 85.6 | 45.6 | 25.5 | 47.6 | 56.1 | 40.4 |
| Basic EPS | 0.98 | 0.96 | 0.91 | 0.49 | 0.66 | 0.70 | 0.88 | 0.47 | 0.26 | 0.50 | 0.58 | 0.44 |
| Diluted EPS | 0.98 | 0.96 | 0.91 | 0.49 | 0.66 | 0.70 | 0.88 | 0.47 | 0.26 | 0.50 | 0.58 | 0.44 |
| Average shares (basic) | 97.4 | 96.9 | 96.8 | 96.8 | 97.3 | 97.9 | 97.3 | 97.2 | 98.1 | 95.2 | 96.7 | 92.3 |
| Average shares (diluted) | 97.4 | 96.9 | 96.8 | 96.8 | 97.3 | 97.9 | 97.3 | 97.2 | 98.1 | 95.2 | 96.7 | 92.3 |
| Dividend per share | — | — | — | 0.69 | — | — | — | 0.69 | — | — | — | 0.69 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7,984 | 8,256 | 7,730 | 5,065 | 3,951 | 2,857 | 1,845 | 1,571 | 1,404 | 1,196 |
| Current assets | 1,441 | 1,741 | 1,415 | 1,671 | 1,456 | 874 | 636 | 553 | 491 | 432 |
| Cash and equivalents | 426 | 679 | 117 | 107 | 224 | 59.8 | 28.2 | 24.0 | 32.6 | 34.8 |
| Short-term investments | 8.1 | 9.9 | 9.5 | 24.8 | 12.7 | 9.8 | 8.4 | 16.6 | 11.3 | — |
| Receivables | 227 | 301 | 334 | 420 | 372 | 264 | 243 | 236 | 238 | 207 |
| Inventory | 691 | 685 | 882 | 1,025 | 783 | 471 | 329 | 252 | 186 | 171 |
| Net property, plant and equipment | 1,431 | 1,163 | 1,036 | 808 | 640 | 519 | 470 | 255 | 228 | 225 |
| Goodwill | 2,884 | 2,908 | 2,885 | 1,136 | 821 | 725 | 418 | 385 | 386 | 345 |
| Other intangible assets | 1,231 | 1,361 | 1,465 | 712 | 563 | 474 | 125 | 111 | 125 | 111 |
| Long-term investments | 19.0 | 24.0 | 40.8 | 24.9 | 14.8 | — | 14.4 | 5.6 | 11.8 | 2.3 |
| Current liabilities | 1,412 | 939 | 937 | 1,036 | 1,037 | 568 | 428 | 382 | 350 | 284 |
| Accounts payable | 278 | 310 | 259 | 252 | 251 | 175 | 117 | 104 | 77.2 | 68.0 |
| Long-term debt | 1,867 | 2,684 | 3,510 | 1,021 | 521 | 516 | 40.0 | 43.1 | 46.3 | 9.4 |
| Total debt | 2,599 | 2,870 | 3,682 | 1,136 | 626 | 587 | 139 | 150 | 160 | 51.3 |
| Total liabilities | 3,858 | 4,233 | 5,056 | 2,551 | 2,218 | 1,396 | 656 | 527 | 524 | 432 |
| Total equity (incl. minority) | 4,126 | 4,024 | 2,674 | 2,514 | 1,733 | 1,461 | 1,189 | 1,045 | 879 | 764 |
| Retained earnings | 2,703 | 2,496 | 2,391 | 2,179 | 1,397 | 1,209 | 899 | 778 | 613 | 490 |
| Minority interest | 35.6 | 37.2 | 35.3 | 64.9 | 77.4 | 22.9 | 30.2 | 8.5 | 7.4 | 5.6 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8,039 | 7,918 | 8,190 | 7,984 | 7,880 | 8,312 | 8,304 | 8,256 | 7,998 | 8,069 | 8,439 | 7,730 |
| Current assets | 1,401 | 1,353 | 1,651 | 1,441 | 1,382 | 1,807 | 1,780 | 1,741 | 1,621 | 1,698 | 2,078 | 1,415 |
| Cash and equivalents | 172 | 204 | 521 | 426 | 299 | 699 | 708 | 679 | 483 | 454 | 695 | 117 |
| Short-term investments | 39.4 | 28.9 | 26.2 | 8.1 | — | 3.5 | — | 9.9 | — | — | — | 9.5 |
| Receivables | 361 | 355 | 303 | 227 | 249 | 303 | 296 | 301 | 316 | 380 | 401 | 334 |
| Inventory | 751 | 714 | 715 | 691 | 723 | 694 | 684 | 685 | 746 | 797 | 873 | 882 |
| Net property, plant and equipment | 2,145 | 2,064 | 2,034 | 1,431 | 1,974 | 1,954 | 1,927 | 1,163 | 1,748 | 1,715 | 1,679 | 1,036 |
| Goodwill | 2,895 | 2,894 | 2,888 | 2,884 | 2,881 | 2,889 | 2,901 | 2,908 | 2,897 | 2,896 | 2,857 | 2,885 |
| Other intangible assets | 1,483 | 1,500 | 1,515 | 1,231 | 1,546 | 1,569 | 1,599 | 1,361 | 1,638 | 1,662 | 1,721 | 1,465 |
| Long-term investments | 22.3 | 20.5 | 19.1 | 19.0 | 22.8 | 21.3 | 23.7 | 24.0 | 35.1 | 36.7 | 41.0 | 40.8 |
| Current liabilities | 1,149 | 1,166 | 1,609 | 1,412 | 1,311 | 946 | 965 | 939 | 758 | 874 | 975 | 937 |
| Accounts payable | 288 | 289 | 293 | 278 | 281 | 347 | 317 | 310 | 193 | 203 | 403 | 259 |
| Long-term debt | 1,915 | 1,942 | 1,861 | 1,867 | 1,867 | 2,684 | 2,684 | 2,684 | 2,684 | 2,684 | 2,985 | 3,510 |
| Total debt | 2,310 | 2,403 | 2,615 | 2,599 | 2,563 | 2,969 | 2,933 | 2,870 | 2,832 | 2,919 | 3,189 | — |
| Total liabilities | 3,648 | 3,671 | 4,047 | 3,858 | 3,807 | 4,273 | 4,296 | 4,233 | 4,059 | 4,145 | 4,572 | 5,056 |
| Total equity (incl. minority) | 4,390 | 4,247 | 4,143 | 4,126 | 4,072 | 4,039 | 4,008 | 4,024 | 3,939 | 3,924 | 3,867 | 2,674 |
| Retained earnings | 2,934 | 2,842 | 2,665 | 2,703 | 2,593 | 2,585 | 2,529 | 2,496 | 2,461 | 2,422 | 2,390 | 2,391 |
| Minority interest | 12.4 | 10.0 | 34.6 | 35.6 | 36.1 | 35.8 | 35.7 | 37.2 | 36.9 | 36.1 | 35.2 | 35.3 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 692 | 815 | 746 | 612 | 702 | 417 | 310 | 227 | 175 | 157 |
| Depreciation and amortization | 266 | 260 | 213 | 162 | 126 | 86.7 | 64.3 | 55.1 | 45.5 | 39.4 |
| Capital expenditure | -393 | -340 | -474 | -431 | -324 | -159 | -136 | -177 | -127 | -79.7 |
| Investing cash flow | -398 | -340 | -2,723 | -958 | -465 | -621 | -184 | -177 | -195 | -103 |
| Financing cash flow | -543 | 84.9 | 1,986 | 221 | -77.7 | 234 | -122 | -59.6 | 16.6 | -50.1 |
| Dividends paid | -67.1 | -67.1 | -133 | -116 | -62.7 | -31.3 | -52.5 | -42.4 | -38.7 | -30.7 |
| Share repurchases | — | -1.9 | — | -3.2 | — | — | — | — | — | — |
| Debt issued | 13.3 | 17.3 | 2,649 | 567 | 74.2 | 335 | 0.7 | 12.8 | 61.0 | 19.0 |
| Debt repaid | -335 | -879 | -326 | -174 | -79.7 | -35.3 | -60.5 | -22.8 | -3.3 | -35.4 |
| Effect of exchange rates | -4.5 | 2.3 | -0.3 | 8.0 | 4.8 | 1.8 | 0.6 | 0.3 | 1.4 | -0.9 |
| Net change in cash | -253 | 562 | 9.5 | -117 | 164 | 31.6 | 4.2 | -8.6 | -2.2 | 2.9 |
| Free cash flow | 299 | 475 | 273 | 182 | 378 | — | — | — | — | — |
| Levered free cash flow | 177 | 370 | 81.1 | 93.9 | 425 | 219 | 149 | 29.2 | 74.3 | 61.1 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 156 | 148 | 193 | 247 | 201 | 125 | 120 | 285 | 259 | 216 | 55.4 | 336 |
| Depreciation and amortization | 81.8 | 79.4 | 81.1 | 31.6 | 78.9 | 77.9 | 77.4 | 38.4 | 76.2 | 74.5 | 70.4 | 38.1 |
| Capital expenditure | -89.5 | -72.8 | -69.6 | -117 | -135 | -75.9 | -65.3 | -80.0 | -70.4 | -80.2 | -109 | -103 |
| Investing cash flow | -90.9 | -72.8 | -69.6 | -119 | -137 | -76.9 | -65.3 | -80.2 | -70.4 | -80.2 | -109 | -105 |
| Financing cash flow | -100 | -395 | -29.2 | 0.9 | -465 | -53.3 | -25.6 | -11.4 | -160 | -376 | 632 | -214 |
| Dividends paid | 0.0 | -67.1 | — | 0.0 | 0.0 | -67.1 | — | 0.0 | 0.0 | -67.1 | — | — |
| Share repurchases | — | 2.4 | -2.9 | — | -3.1 | 1.1 | -2.0 | — | — | -5.9 | — | — |
| Debt issued | 0.0 | 295 | 0.0 | 0.4 | 0.0 | 12.9 | — | 3.7 | 0.0 | 13.6 | — | — |
| Debt repaid | -12.4 | -536 | -14.7 | 0.0 | -321 | 0.0 | -13.7 | -9.1 | -29.8 | -289 | -551 | -113 |
| Effect of exchange rates | 3.2 | 2.2 | 0.5 | -1.2 | 0.0 | -3.0 | -0.3 | 3.1 | 0.2 | -0.9 | -0.1 | 0.4 |
| Net change in cash | -31.8 | -317 | 95.1 | 127 | -401 | -8.4 | 28.7 | 196 | 28.5 | -241 | 578 | 17.3 |
| Free cash flow | 66.9 | 75.1 | 124 | 129 | 66.1 | 49.0 | 54.5 | 205 | 188 | 136 | -53.8 | 233 |
| Levered free cash flow | 33.7 | -89.3 | 125 | 181 | -34.4 | -29.7 | 40.6 | 290 | 136 | 22.6 | -86.9 | 126 |
Financial statements of similar companies
Companies in the group: same industry, similar size
